data showed that the contractile responses to KCl, carbachol and EFS were significantly increased in detrusor strips from Dahl control rats compared to those from the other three groups.
INTRODUCTION AND OBJECTIVES:
This study aims to express urinary MCP-1 level in OAB patients before and after treatments, and to correlate the level of MCP-1 with severity of symptoms.
METHODS: This was a prospective, single-blind study including 26 OAB patients (either newly diagnosed or off medications for 2 weeks). Each patient received after the first visit different OAB treatments (anticholinergic, B3 agonist and or neuromodulations). Two midstream urine samples were collected and tested for MCP-1 using ELISA; one before and the second after 12 weeks of treatments. Symptomatic responses to therapy were evaluated using different validated OAB questionnaires [Patient Perception Bladder Condition (PPBC) & Overactive Bladder Quality (OAB-q)]. MCP-1 level were normalized to the levels of creatinine. Descriptive statistics were performed to examine MCP-1 level before and after different using Wilconxon test. Post-treatment MCP1-levels compared to 12 healthy subjects as control using Mann-Whitney U test.
RESULTS: The mean age of enrolled 26 patients was 69.3yrs. Females accounted for 62.5% of patients. In simple correlation, the degrees of symptoms was significantly associated with the pre-treatment level of MCP-1 (coefficient¼.844, p<.000 in PPBC and coefficient¼.869, p<.000 in OABq, Figure 1 ). Mulivariate analysis using linear regression model including age, gender and MCP-1 demonstrated that MCP-1 was significantly associated with OABq (p¼.02) and PPBC (p¼.03). Twelve weeks after treatment, MCP-1 level was dropped significantly (p<.000), and it was similar with control group (p¼0.376, Table) . After treatment, the symptom improved significantly both in OAB-q and PPBC (Figure 2) .
CONCLUSIONS: Based on a strong association with the degree of symptom, urinary MPC-1 can be used to identify patients and monitor the progression of OAB.
Source of Funding: none

MP26-18 TIME-DEPENDENT BLADDER AND URETHRAL DYSFUNCTIONS IN AGING RATS
Takuma Oshiro*, Naha, Okinawa, Japan; Minoru Miyazato, Asuka Ashikari, Seiich Saito, Nishihara, Okinawa, Japan INTRODUCTION AND OBJECTIVES: Age-related symptoms such as urinary retention, poor urine flow, and/or incontinence have been attributed to detrusor underactivity (DU). Our recent data showed that in continuous cystometry, bladder contractility did not diminish but post-void residual urine volume was higher in aging rats than in young rats. Thus, the assumption that bladder and urethral dysfunction occur simultaneously in aging rats seems reasonable. Therefore, we investigated this possibility by measuring time-dependent changes of bladder and urethral functions in rats.
METHODS: Female Sprague-Dawley rats (young rats aged 3 months and rats aged 12 and 24 months) were used. 1) Continuous cystometry was performed under awake condition in each group. 2) Urethral activity was evaluated by simultaneous recordings of intravesical pressure under isovolumetric conditions and urethral perfusion pressure (UPP) under urethane anesthesia in 3-month-old and 12-month-old rats. 3) Masson's trichrome staining in the bladder was performed in each group.
RESULTS: 1) Cystometric evaluations revealed that the intercontraction intervals in the 24-month-old rats were prolonged (p < 0.01) when compared with those in the 3-month-old or 12-month-old rats. In the 24-month-old rats, residual urine volume was significantly higher than in the 3-month-old or 12-month-old rats, and non-voiding contractions were prominent. However, the amplitude of bladder contraction did not differ among the three groups. 2) UPP relaxation (baseline UPP minus nadir UPP) was more significantly diminished (64%) in the 12-month-old rats than in the 3-month-old rats (p < 0.05). The mean rate and amplitude of high-frequency oscillation (HFO) of urethral striated muscle were also significantly lower (12% and 41%, respectively) in the 12-month-old rats than in the 3-month-old rats. 3) In the bladders of the 24-month-old rats, increases in smooth muscle cell hypertrophy and fibrous tissue were observed.
CONCLUSIONS: 1) Our aging model that focused on bladder function showed increased intercontraction intervals and non-voiding bladder contractions with increased residual urine volume, suggesting detrusor hyperactivity with impaired contractility bladder activity. 2) Our e326 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 aging model that focused on urethral function indicates urethral dysfunction, as evident from the reduction in HFO activity of the urethral striated muscle and the urethral relaxation. Thus, age-associated bladder and urethral dysfunction seem likely to occur simultaneously, which leads to DU with a vicious cycle. In a previous study, 5-hydroxytryptamine (5-HT) was found to induce hyper contraction in urinary bladder strips in rats with partial bladder outlet obstruction (pBOO) and 5-HT was suggested to be a trigger of hyper contractility of the detrusor [Sakai T. et al. 2013] . To clarify whether 5-HT contributes to the development of detrusor overactivity and whether 5-HT turnover is involved in overactivity in vivo, we investigated the expression and activity of monoamine oxidase A (MAO-A), a 5-HT-metabolizing enzyme, in the urinary bladder in pBOO rats.
METHODS: Forty-one Female Sprague Dawley rats (aged 8-11 weeks) were used; 12 rats for histology, and 29 rats for western blotting and MAO activity assay. pBOO was induced as described previously [Sakai T. et al. 2013] . At 3, 7, and 14 days after pBOO induction, animals were anesthetized, and urinary bladders were isolated and fixed for histology, or were stored at -80 C until use for western blotting and MAO activity assay to measure expression levels of MAO-A and activity of MAO, respectively. The distribution of MAO-A in the bladder was examined by immunohistochemistry. MAO activity was measured by MAO-Glo' Assay. All values were expressed as means AE SEM. Statistical differences were determined by unpaired t-test using SAS System ver. 9.2 and EXSUS ver. 7.7.1. P values of <0.05 were considered significant.
RESULTS: Expression levels of MAO-A/GAPDH decreased to 46.2 AE 2.7% on day 7 in rat bladders with pBOO (P<0.01) as compared to those in sham rats (Fig) . MAO activity in rat urinary bladders also decreased to 48.9 AE 2.9% on day 7 pBOO (P<0.01) as compared to sham rats. The decrease in MAO activity persisted on day 14 (P<0.01). On immunohistochemistry, MAO-A-positive cells were predominantly observed in the detrusor layer in sham rat bladders. In pBOO rats, in contrast, the intensity of the MAO-A-positive signal decreased overall as compared to sham rats.
CONCLUSIONS: We demonstrated that the levels of MAO-A and activity of MAO decreased in the urinary bladder from pBOO rats as compared with sham rats. These results suggest that downregulation of 5-HT degradation leads to detrusor hypercontractility and/or facilitates hyper-contraction induced by 5-HT in the urinary bladder in pBOO rats.
Source of Funding: Asahi Kasei Pharma Co.
MP26-20 EFFECTS OF DECREASED ESTROGEN ON LOWER URINARY TRACT FUNCTION AND ASSESSMENT OF PURINERGIC SYSTEM CHANGES IN THE GUINEA PIG BLADDER
Nobuhiro Kushida*, Junya Yoshida, Hidenori Akaihata, Kei Ishibashi, Yoshiyuki Kojima, Fukushima, Japan INTRODUCTION AND OBJECTIVES: Decreased serum estrogen is known to cause lower urinary tract symptoms. Adenosine triphosphate (ATP) is considered to be a bioactive substance that modulates bladder function. The purpose of this study was to assess changes in purinergic regulation systems in the bladder wall, including ATP released from the urothelium, using an ovariectomy model.
METHODS: Twenty female guinea pigs (weight: 450-550 g) were divided into an ovariectomy group (OVX; n¼10), which received bilateral ovariectomy to induce surgical menopause, and a sham operation group (Sham; n¼10). All animals were housed in metabolic cages for 24 hours at 4 weeks after the operation. An intact strip, which contains the whole bladder layer, was stimulated by purinergic agents (e.g., ATP, a,b-methylene ATP, ADP), carbachol (CCh; 10 -8 M to 10 -5 M), and by electrical field stimulation (EFS; 1-40 Hz, duration 0.5 msec). Mucosal strips including urothelium were prepared by dissection between the suburothelial and detrusor layers. The concentration of ATP perfusing through the strips was measured using a luciferine-luciferase assay. RESULTS: The serum b-estradiol level was significantly lower in the OVX group, and uterine weight was less in the OVX group (OVX 227.4, Sham 1475 mg, p<0.001). In the OVX group, 24-hour urination frequency increased, and the mean voided urine volume decreased. 10 mN of passive stretch of mucosal strips increased the ATP concentration in both groups, and the rate of increase was significantly higher in the OVX group (226.5%) than in the Sham group (127.6%). Since the response to CCh in intact strips was significantly smaller in the OVX group (pEC 50 ; 6.21) than in the Sham group (6.36), the contractile response to ATP was higher in the OVX group (10 -3 M: Sham 787.0, OVX 986.6 mN/g). Contractile responses to 10 -4 M ADP and 10 -5 M a,b-methylene ATP were also larger in the OVX group. Although the total contractile response to EFS was similar in both groups, atropine-resistant contraction was increased in the OVX group (24 Hz: Sham 39.2, OVX 58.7% normalized by Tmax). Moreover, the correlation coefficient between the tension of intact strips stimulated by EFS and ATP release from them was larger in the OVX group than in the Sham group (4 Hz: r 2 ¼ Sham 0.342, OVX 0.578).
CONCLUSIONS: Detrusor contractility to CCh decreased in the OVX group, though the purinergic system for bladder contraction and ATP release were upregulated in the OVX group. It appeared that the purinergic system compensated for bladder contractility. Increasing ATP release from the mucosa may upregulate bladder sensation.
